Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Carcinogenesis|June 6, 2023
Combined Wee1 and EGFR inhibition reveals synergistic antitumor effect in esophageal squamous cell carcinomaDongshao Chen, Ruoxi Hong, Youjun Cao, et al.BMC Cancer|September 15, 2023
Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomesKuikui Jiang, Danyang Zhou, Fei Xu, et al.Breast Cancer Research and Treatment|May 5, 2024
Multi-omics portrait of ductal carcinoma in situ in young womenRuoxi Hong, Boyang Cao, Dongshao Chen, et al.NPJ Breast Cancer|April 21, 2023
The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancerDanyang Zhou, Mei Li, Mohamed Hussein Yasin, et al.Breast Cancer Research and Treatment|September 25, 2016
Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysisQiufan Zheng, Wen Xia, Qianyi Lu, et al.Frontiers in Oncology|December 3, 2021
Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast CancerDanyang Zhou, Kuikui Jiang, Ruoxi Hong, et al.Frontiers in Oncology|October 11, 2021
Miller-Payne Grading and 70-Gene Signature Are Associated With Prognosis of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer After Neoadjuvant ChemotherapyLiye Wang, Rongzhen Luo, Qianyi Lu, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 9, 2015
[Comparison of the effectiveness of platinum-based chemotherapy versus non-platinum-based chemotherapy for triple-negative breast cancer with metastases confined to the lungs]Ruoxi Hong, Fei Ma, Xiuqing Shi, et al.Thoracic Cancer|March 26, 2018
Analysis of the activity and safety of weekly low-dose bevacizumab-based regimens in heavily pretreated patients with metastatic breast cancerXiaoyu Zhai, Ruoxi Hong, Ying Fan, et al.Plos One|May 30, 2020
PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancerDanna Yeerken, Ruoxi Hong, Yan Wang, et al.Pageof 6